BIOMAT Database Logo BIOMAT Database Logo

[Biochemical and hemodynamic indicators in acute myocardial infarct]. 1978

A G Ponomareva, and V I Shepotinovskiĭ, and V P Terent'ev, and Z I Mikashinovich

UI MeSH Term Description Entries
D007521 Isocitrate Dehydrogenase An enzyme of the oxidoreductase class that catalyzes the conversion of isocitrate and NAD+ to yield 2-ketoglutarate, carbon dioxide, and NADH. It occurs in cell mitochondria. The enzyme requires Mg2+, Mn2+; it is activated by ADP, citrate, and Ca2+, and inhibited by NADH, NADPH, and ATP. The reaction is the key rate-limiting step of the citric acid (tricarboxylic) cycle. (From Dorland, 27th ed) (The NADP+ enzyme is EC 1.1.1.42.) EC 1.1.1.41. NAD Isocitrate Dehydrogenase,Isocitrate Dehydrogenase (NAD+),Isocitrate Dehydrogenase-I,Dehydrogenase, Isocitrate,Dehydrogenase, NAD Isocitrate,Isocitrate Dehydrogenase I,Isocitrate Dehydrogenase, NAD
D008291 Malate Dehydrogenase An enzyme that catalyzes the conversion of (S)-malate and NAD+ to oxaloacetate and NADH. EC 1.1.1.37. Malic Dehydrogenase,NAD-Malate Dehydrogenase,Dehydrogenase, Malate,Dehydrogenase, Malic,Dehydrogenase, NAD-Malate,NAD Malate Dehydrogenase
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D003402 Creatine Kinase A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins. Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D005260 Female Females
D005954 Glucosephosphate Dehydrogenase Glucose-6-Phosphate Dehydrogenase,Dehydrogenase, Glucose-6-Phosphate,Dehydrogenase, Glucosephosphate,Glucose 6 Phosphate Dehydrogenase
D005956 Glucose-6-Phosphate Isomerase An aldose-ketose isomerase that catalyzes the reversible interconversion of glucose 6-phosphate and fructose 6-phosphate. In prokaryotic and eukaryotic organisms it plays an essential role in glycolytic and gluconeogenic pathways. In mammalian systems the enzyme is found in the cytoplasm and as a secreted protein. This secreted form of glucose-6-phosphate isomerase has been referred to as autocrine motility factor or neuroleukin, and acts as a cytokine which binds to the AUTOCRINE MOTILITY FACTOR RECEPTOR. Deficiency of the enzyme in humans is an autosomal recessive trait, which results in CONGENITAL NONSPHEROCYTIC HEMOLYTIC ANEMIA. Glucosephosphate Isomerase,Phosphoglucose Isomerase,Phosphohexose Isomerase,Autocrine Motility Factor,Isomerase, Glucose 6 Phosphate,Neuroleukin,Tumor Autocrine Motility Factor,Tumor-Cell Autocrine Motility Factor,Factor, Autocrine Motility,Glucose 6 Phosphate Isomerase,Isomerase, Glucose-6-Phosphate,Isomerase, Glucosephosphate,Isomerase, Phosphoglucose,Isomerase, Phosphohexose,Motility Factor, Autocrine,Tumor Cell Autocrine Motility Factor
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic

Related Publications

A G Ponomareva, and V I Shepotinovskiĭ, and V P Terent'ev, and Z I Mikashinovich
[Hemodynamic observations in acute myocardial infarct].
February 1977, Kardiologiia,
A G Ponomareva, and V I Shepotinovskiĭ, and V P Terent'ev, and Z I Mikashinovich
[Hemodynamic changes following acute myocardial infarct].
August 1967, Klinische Wochenschrift,
A G Ponomareva, and V I Shepotinovskiĭ, and V P Terent'ev, and Z I Mikashinovich
[Hemodynamic variants of acute myocardial infarct].
January 1979, Kardiologiia,
A G Ponomareva, and V I Shepotinovskiĭ, and V P Terent'ev, and Z I Mikashinovich
[Biochemical markers in acute myocardial infarct].
July 1996, Bratislavske lekarske listy,
A G Ponomareva, and V I Shepotinovskiĭ, and V P Terent'ev, and Z I Mikashinovich
[RENAL HEMODYNAMIC VARIATIONS IN ACUTE MYOCARDIAL INFARCT].
January 1965, Minerva cardioangiologica,
A G Ponomareva, and V I Shepotinovskiĭ, and V P Terent'ev, and Z I Mikashinovich
[Hemodynamic basis of acute myocardial infarct therapy].
June 1975, Deutsche medizinische Wochenschrift (1946),
A G Ponomareva, and V I Shepotinovskiĭ, and V P Terent'ev, and Z I Mikashinovich
[Biochemical diagnosis of acute myocardial infarct].
February 2000, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
A G Ponomareva, and V I Shepotinovskiĭ, and V P Terent'ev, and Z I Mikashinovich
[Hemodynamic effects of furosemide in acute myocardial infarct].
February 1978, Revista do Hospital das Clinicas,
A G Ponomareva, and V I Shepotinovskiĭ, and V P Terent'ev, and Z I Mikashinovich
[Significance of hemodynamic monitoring in acute myocardial infarct].
April 1981, Minerva cardioangiologica,
A G Ponomareva, and V I Shepotinovskiĭ, and V P Terent'ev, and Z I Mikashinovich
[Hemodynamic effects of nitroglycerin in acute myocardial infarct].
October 1982, Kardiologiia,
Copied contents to your clipboard!